NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/06/2026
Voltar para busca
Dado oficial do USPTO
KYXINKO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
25/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
06/11/2020
Data de registro
20/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/09/2022
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
ES
Examinador
LOBO, DEBORAH E
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LABORATORIOS FARMACEUTICOS ROVI, S.A.
Representantes
Andrew M. Smith Resonate IP, LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productsantibioticsanalgesicsanesthetics for surgical and non-surgical useamino acids for medical useantisepticstranquilizerscollyriumsdigestives for pharmaceutical purposeslaxativesprescription synthetic narcotics; chemical products for medical usepharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of central nervous system diseases; medicines for the treatment of headache in the form of tonics; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; contraceptive preparations; vaccinessyringesvialscartridges or carpules and ampoules for medical purposesall sold pre-filled with pharmaceutical preparations in the nature of antipsychotics; implantable subcutaneous pharmaceutical delivery devices sold pre-filled with insulin; implantable drug delivery devices sold pre-filled with contraceptives; Pharmaceuticalsoncological preparations for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; preparations for the treatment of allergiesfor disorders of the skinthrombosiscoagulation diseasesinfectionsflupain and inflammation; tranquilizersprescription synthetic narcoticsantidepressantsanxiolytics; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/10/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/10/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/10/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/01/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/12/2022
FIMP
FINAL DISPOSITION PROCESSED
22/12/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
20/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2022
PUBO
PUBLISHED FOR OPPOSITION
05/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/06/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
30/05/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/05/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
30/05/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/05/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
25/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/05/2022
RFNT
REFUSAL PROCESSED BY IB
13/03/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/02/2022
RFRR
REFUSAL PROCESSED BY MPU
24/02/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/01/2022
CNRT
NON-FINAL ACTION WRITTEN
28/01/2022
DOCK
ASSIGNED TO EXAMINER
22/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
15/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/01/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/01/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KYXINKO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.